Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement

Endocrine Journal

Volumn 46, Issue 6, 1999, Pages 747-754

  Kusaka, Ikuyo ^a   Nagasaka, Shoichiro ^a   Fujibayashi, Kazutoshi ^a   Hayashi, Hiroko ^a   Kawakami, Akio ^a   Nakamura, Tomoatsu ^a   Rokkaku, Kumiko ^a   Saito, Takako ^a   Higashiyama, Minori ^a   Honda, Kazufumi ^a   Ishikawa, San E ^a   Saito, Toshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti GAD antibody; CTLA 4; Diabetes mellitus; Graves' disease; HLA

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ANTIBODY DETECTION; ARTICLE; FEMALE; GENE FREQUENCY; GENE LOCATION; GRAVES DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

EID: 0033375174     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.46.747     Document Type: Article

References (34)

1. The expert committee on the diagnosis and classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197.
2. Kida K, Mimura G, Kobayashi T, Nakamura K, Sonoda S, Inouye H, Tsuji K (1989) Immunogenetic heterogeneity in Type 1 (insulin-dependent) diabetes among Japanese-HLA antigen and organ-specific autoantibodies. Diabetologia 32: 34-39.
3. Mimura G, Kida K, Matsuura N, Toyota T, Kitagawa T, Kobayashi T, Hibi I, Ikeda Y, Tuchida I, Kuzuya H, Aono S, Doi K, Nishimukai H, Jinnouchi T, Murakami K (1990) Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organ-specific autoantibodies - the J.D.S. study. Diabetes Res Clin Pract 8: 253-262.
4. Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J, Rosenbloom AL (1980) Islet cell and other organ-specific antibodies in U.S. Caucasians and blacks with insulin-dependent diabetes mellitus. Diabetes 20: 589-592.
5. Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS (1994) HLA-DQB1-associated susceptibility that distinguishes Hashimoto's thyroiditis from Graves' disease in type I diabetes patients. J Clin Endocrinol Metab 78: 878-883.
6. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH (1995) Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80: 2112-2117.
7. Chuang LM, Wu HP, Chang CC, Tsai WY, Chang HM, Tai TY, Lin BJ (1996) HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus. Clin Endocrinol 45: 631-636.
8. Solimena M, Folli F, Dennis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM (1998) Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and Type 1 diabetes mellitus. N Engl J Med 318:1012-1020.
9. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olsen H, Camilli PD (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156.
10. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ (1990) 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357-1360.
11. De Aizpurua HJ, Wilson YM, Harrison LC (1992) Glutamic acid decarboxylase autoantibodies in pre-clinical insulin-dependent diabetes. Proc Natl Acad Sci USA 89: 9841-9845.
12. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark A (1994) Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19: 113-125.
13. Chikuba N, Akazawa S, Yamaguchi Y, Kawasaki E, Takino H, Takao Y, Maeda Y, Okuno S, Yamamoto H, Yokota A, Yoshimoto M, Nagataki S (1992) Type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune thyroid disease in Japan. Intern Med 31: 1076-1080.
14. Chikuba N, Akazawa S, Yamaguchi Y, Kawasaki E, Takino H, Yoshimoto M, Ohe N, Yamashita K, Yano A, Nagataki S (1995) Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese-class II antigen and autoimmune thyroid disease. Diabetes Res Clin Pract 27: 31-37.
15. Kawasaki E, Takino H, Yano M, Uotani S, atsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S (1994) Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86.
16. Cooppan R, Kozak GP (1980) Hyperthyroidism and diabetes mellitus. An analysis of 70 patients. Arch Intern Med 140: 370-373.
17. Mouradian M, Abourizk N (1983) Diabetes mellitus and thyroid disease. Diabetes Care 6: 512-520.
18. WHO Study Group (1985) Diabetes mellitus. World Health Organization, WHO, Geneva, Technical Report Series 727.
19. Kuzuya T, Matsuda A (1997) Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes Care 20: 219-220.
20. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y (1995) Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28: 191-199.
21. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC (1994) High level of concordance between assays for glutamic acid decarboxylase antibodies. The first international glutamic acid decarboxylase antibody workshop. Diabetes 43: 1005-1009.
22. Schmidli RS, Colman PG, Bonifacio E (1995) Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes 44: 636-640.
23. Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y (1998) Comparison of GAD and ICA512 /IA-2 antibodies at and after the onset of IDDM. Diabetes Care 21: 49-52.
24. Matsuda A, Kuzuya T, Iwamoto Y, Yoshioka N, Awata T, Kumakura S, Ohwada N (1998) HLA DR antigens in adult-onset and juvenile-onset Japanese insulin-dependent diabetic patients. Diabetes Res Clin Pract 5: 107-112.
25. Ikegami H, Kawaguchi Y, Yamato E, Kuwata S, Tokunaga K, Noma Y, Shima K, Ogihara T (1992) Analysis by the polymerase chain reaction of histo-compatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 75: 1381-1385.
26. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves' diasease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82: 143-146.
27. Hallengren B, Falorni A, Landin-Olsson M, Lernmark A, Papadopoulos KI, Sundkvist G (1996) Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 239: 63-68.
28. Kobayashi T, Nakanishi K, Murase T, Kosaka K (1996) Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45: 622-626.
29. Imagawa A, Hanafusa T, Itoh N, Waguri M, Yamamoto K, Miyagawa J, Moriwaki M, Yamagata K, Iwahashi H, Sada M, Tsuji T, Tamura S, Kawata S, Kuwajima M, Nakajima H, Namba M, Matsuzawa Y (1999) Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 42: 574-578.
30. Nordyke RA, Girbert FI, Harada ASM (1998) Graves' disease. Influence of age on clinical findings. Arch Intern Med 148: 626-631.
31. Chambers CA, Allison JP (1997) Co-stimulation in T cell responses. Curr Opin Immunol 9: 396-404.
32. Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S (1998) Association of CTLA-4 gene A-G polymorphism (IDDM 12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47: 128-129.
33. Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, Saruta T (1997) CTLA-4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 7: 843-836.
34. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach JF, Caillat-Zucman S (1998) No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 47: 125-127.